Sitemap

Milija Zeković, SBB CEO

Technological Innovations Are In Our DNA

We want to enter the mobile telecommunications market and offer our users 4P services, i.e., a combination of broadband internet access, television and fixed-line...

Maria Boldor, Principal At Horváth

Key Challenges & Opportunities

The report “Finance at the Crossroads of Coronavirus, Digitalisation and Sustainability” presents key challenges and opportunities for the business world Management consulting company Horváth published...

Nataša Bezmarević, Branch Manager Serbia, DB Engineering & Consulting GmbH

Focus On Electrifying Train Lines

Deutsche Bahn has been providing engineering, consulting and train operation services, as well as digital systems, for many years and has successfully implemented railway...

Porto Montenegro

A Life Less Ordinary

Founded some 15 years ago by a consortium of visionary developers, Porto Montenegro is set in the spectacularly beautiful Bay of Kotor on Montenegro’s...

Ivan Crnojević, CEO, ELMED d.o.o.

ELMED – We can do more

The future belongs to modern, innovative companies that carefully plan and strategically manage their business. For this reason, Elmed doo in Temerin, winner of...

Nebojša Škuljec, Director, Merck Sharp & Dohme

Committed To Patients’ Health In Serbia

For 130 years, Merck Sharp & Dohme has been inventing for life, bringing medicines and vaccines for many of the world’s most challenging diseases in the pursuit of its company mission to save and improve lives

We need to continue in the same direction, and once we close the gap on EU countries, we need to have continuous and sustainable investment behind innovation, in parallel with reducing inefficiencies in the healthcare system,” says Merck Sharp & Dohme Director Nebojša Škuljec.

Has the pharmaceutical industry been working over the past year to develop new therapies for diseases that we neglected and disregarded as a result of the arrival of COVID-19?

Prior to COVID-19, most resources and efforts were focused on developing new drugs for oncology and non-communicable diseases. MSD made a breakthrough in oncology treatment several years ago, with the development of the first immunooncology drug, Keytruda®, which showed remarkable results that have been confirmed by the now five-year survival data on some of the deadliest forms of cancer, such as malignant melanoma and lung cancer. We’re continuing to investigate and demonstrate the benefits of Keytruda® in a range of malignant diseases, but we’ve also strengthened our commitment to fighting infectious diseases. In parallel with developing new powerful antibiotics that are needed to address growing antimicrobial resistance, MSD is investing a lot of effort into delivering quickly on the new potent anti-COVID drug. Our Molnupiravir molecule has been shown to be active in several models of SARS-CoV-2.

Patients in the U.S. can take advantage of the availability of the latest therapies. How can we reduce the availability gap compared to such developed countries?

Besides investing in the development of new medicines, it is also important that innovations are accessible and affordable to the patients who need them. Spending on medicines as a percentage of overall healthcare expenditure ranges from five to 10 percent in most developed countries, to as much as 60 percent in many emerging economies.

Merck Sharp & Dohme aspires locally to be the most-trusted partner to Serbian Government, healthcare institutions and health workers

All healthcare systems worldwide aim to secure mechanisms to control healthcare costs while serving the need for breakthrough treatments. Serbia has come a long way in the past several years, in terms of access to innovative medicines, followed by increased investment that has resulted in much better outcomes for patients.

The second important task for policymakers and the pharmaceutical industry is to expand public-private partnerships, like the latest one coming from our company, which relates to the aforementioned anti-COVID drug Molnupiravir. We believe that this kind of partnership, as well as advanced purchase agreements, are also possible in other countries, and we are actively engaged in numerous efforts to ensure Molnupiravir is also available in Serbia, immediately after global healthcare giants like the U.S.

Are you preparing to celebrate the 25th anniversary of your operations in Serbia? What is behind you, and what lies ahead?

We’ve demonstrated the same commitment to patients and the health of the population in Serbia over the past 25 years by increasing access to healthcare through far-reaching policies, programs and partnerships. Today, we continue to be at the forefront of research aimed at preventing and treating diseases that threaten people’s lives, just as we also aspire locally to be the most-trusted partner of the Serbian Government, healthcare institutions and health workers.

Milija Zeković, SBB CEO

Technological Innovations Are In Our DNA

We want to enter the mobile telecommunications market and offer our users 4P services, i.e., a combination of broadband internet access, television and fixed-line...

Maria Boldor, Principal At Horváth

Key Challenges & Opportunities

The report “Finance at the Crossroads of Coronavirus, Digitalisation and Sustainability” presents key challenges and opportunities for the business world Management consulting company Horváth published...

Nataša Bezmarević, Branch Manager Serbia, DB Engineering & Consulting GmbH

Focus On Electrifying Train Lines

Deutsche Bahn has been providing engineering, consulting and train operation services, as well as digital systems, for many years and has successfully implemented railway...

Porto Montenegro

A Life Less Ordinary

Founded some 15 years ago by a consortium of visionary developers, Porto Montenegro is set in the spectacularly beautiful Bay of Kotor on Montenegro’s...

China: Ready To Promote Global Development

The Forum on Global Development was held in Beijing, and on that occasion the President of the People's Republic...

Serbia And Hungary Sign Agreement On Border Control

The Agreement between the governments of Serbia and Hungary regulating border control in road, rail and water transport was...

Reception On The Occasion Of 140 Years Of Friendly Relations Between Japan And Serbia

Ambassador of Japan in Serbia H.E. Katsumata Takahiko hosted a reception in his residence to mark the 140th anniversary...

Nikola Jokic And Nuggets Agree On Historic 5-year Extension

Nikola Jokic has gone from draft pick No. 41, to two-time MVP, and now the holder of the largest...

Japanese Investors Welcome To Serbia

Prime Minister Ana Brnabic and President of the Republic Aleksandar Vucic attended a reception marking 140 years of the...

China: Ready To Promote Global Development

The Forum on Global Development was held in Beijing, and on that occasion the President of the People's Republic...

Serbia And Hungary Sign Agreement On Border Control

The Agreement between the governments of Serbia and Hungary regulating border control in road, rail and water transport was...

Reception On The Occasion Of 140 Years Of Friendly Relations Between Japan And Serbia

Ambassador of Japan in Serbia H.E. Katsumata Takahiko hosted a reception in his residence to mark the 140th anniversary...

Nikola Jokic And Nuggets Agree On Historic 5-year Extension

Nikola Jokic has gone from draft pick No. 41, to two-time MVP, and now the holder of the largest...

EU Agrees On Rules To Tame Crypto Market

The European Union has agreed on ground-breaking rules for regulating crypto assets, EU lawmakers said on Thursday, as the...

China: Ready To Promote Global Development

The Forum on Global Development was held in Beijing, and on that occasion the President of the People's Republic...

Serbia And Hungary Sign Agreement On Border Control

The Agreement between the governments of Serbia and Hungary regulating border control in road, rail and water transport was...

Reception On The Occasion Of 140 Years Of Friendly Relations Between Japan And Serbia

Ambassador of Japan in Serbia H.E. Katsumata Takahiko hosted a reception in his residence to mark the 140th anniversary...

Nikola Jokic And Nuggets Agree On Historic 5-year Extension

Nikola Jokic has gone from draft pick No. 41, to two-time MVP, and now the holder of the largest...

EU Agrees On Rules To Tame Crypto Market

The European Union has agreed on ground-breaking rules for regulating crypto assets, EU lawmakers said on Thursday, as the...
spot_img